Novel Thienyl-Based Tyrosine Kinase Inhibitors for the Treatment of Hepatocellular Carcinoma

New medical treatments are urgently needed for advanced hepatocellular carcinoma (HCC). Recently, we showed the anticancer effects of novel thiophene-based kinase inhibitors. In this study, we further characterized the antineoplastic effects and modes of action of the two most promising inhibitors,...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Andi, Biersack, Bernhard, Goehringer, Nils, Nitzsche, Bianca, Höpfner, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146161/
https://www.ncbi.nlm.nih.gov/pubmed/35629160
http://dx.doi.org/10.3390/jpm12050738

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146161/
https://www.ncbi.nlm.nih.gov/pubmed/35629160
http://dx.doi.org/10.3390/jpm12050738

Ejemplares similares